Delivery Order SPE2DR25D3004-SPE2DR26FXPT9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,064.84 to AmerisourceBergen Drug Corp for the supply of CAPLYTA 21 mg capsules (30-count units) under a firm fixed price contract. The award was made on November 25, 2025, with an ultimate completion date of November 26, 2025, and represents a non-competitive set-aside transaction. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order from its...
- The Defense Logistics Agency awarded a $3,022.90 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Caplyta 21 mg capsules (30-count units). The contract, classified as firm fixed price with no set-aside designation, is a competitively awarded delivery order with an ultimate completion date of August 27, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. This award represents a continuation...
- The Defense Logistics Agency awarded a $2,088.32 delivery order to AmerisourceBergen Drug Corp for CAPLYTA 21 mg capsules (30-count package) on November 24, 2025, with completion expected by November 25, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-unit packages) with a ceiling value of $2,971.27 under firm fixed pricing. The award, issued on November 7, 2025, with an ultimate completion date of November 10, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 16, 2025, for the supply of CAPLYTA 42 mg capsules in a quantity of 30 units. This firm fixed price delivery order, valued at $29,358.50 with an ultimate completion date of September 17, 2025, represents a non-set-aside competitive award. The contract will be performed at the awardee's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,543.88 to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-count units) under a firm fixed-price contract. The award was made on September 22, 2025, with an ultimate completion date of September 23, 2025, and represents a non-set-aside competitive procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $16,800.83 to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-count units) under a firm fixed-price contract. The award, issued on November 14, 2025, with an ultimate completion date of November 17, 2025, represents a non-set-aside competitive award. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CAPLYTA 42 mg capsules (30-count) valued at $12,179.63 under a firm fixed-price contract. The award was made on November 24, 2025, with an ultimate completion date of November 25, 2025, and represents a non-set-aside competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-count) valued at $1,535.61 under a firm fixed price contract. The award was made on December 8, 2025, with an ultimate completion date of December 9, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $10.7K delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Caplyta 42 mg capsules (30-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract will be completed by May 9, 2025, and the pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXPT9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of CAPLYTA 10.5 mg capsules (30-count units) valued at $3,299.95 under a firm fixed-price contract. This non-competitive delivery order represents a single transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The place of performance is the company's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of December 10, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The IDC serves as a comprehensive sourcing mechanism enabling AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, and vaccines—to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen demonstrates consistent capability to fulfill federal requirements through open competition and serves Defense Health Agency and other government healthcare systems through this flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 12/8/25 |